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A B S T R A C T
Although elderly hospitalized patients, irrespective of the cause of hospitalization, are known to be at a high risk of
subsequent development of pneumonia, some studies suggest the risk to be even higher in those hospitalized for pneu-
monia than in those hospitalized for other diseases. The aim of this retrospective study was to determine the associa-
tion of hospitalization for pneumonia and some other diseases with subsequent pneumonia morbidity and mortality.
The risk of recurrent pneumonia in patients hospitalized for pneumonia was investigated. Rehospitalization of pneu-
monia patients previously hospitalized for the same disease was followed-up and compared with rehospitalization of
patients hospitalized for other diseases during the same study period. The study included patients aged over18, ini-
tially hospitalized in 1998 for pneumonia (J12–J18), or for some particular gastrointestinal (K20–K31) and urogenital
diseases (N10–N12, N30–N39). All rehospitalizations for pneumonia in nine Zagreb hospitals were followed-up during
a 3-year study period (1998–2000). Out of 975 patients followed-up for rehospitalization, 227 (23.3%) had initially
been hospitalized for pneumonia, and 748 (76.7%) for other diagnoses. During the 3-year period, 30 patients were
rehospitalized for pneumonia, out of which number 22 had initially been hospitalized for pneumonia, yielding a statis-
tically significant difference between the two study groups (2=34.780, p<0.001). The mortality directly caused by
pneumonia was also significantly higher in the group of patients with the initial diagnosis of pneumonia than in the
group of patients with other diagnoses (2=15.82, p<0.001).
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Introduction
Certain population groups are exposed to an in-
creased risk of pneumococcal disease morbidity and
mortality. These groups include the elderly, in whom the
immunity and other natural mechanisms of defense
(e.g., coughing reflex) are impaired due to the advanced
age, which may increase the risk of disease. There are
also other contributing factors such as inadequate phys-
ical activity, multimorbidity, and inappropriate dietary
habits1. Some authors refer to advanced age as an inde-
pendent risk factor2, confirmed by the data obtained in a
10-year study conducted in Great Britain by Aszkenasy
et al., where more than a half of pneumococcal bac-
teremia patients were aged 653. Studies from the Uni-
ted States of America (USA) report on the annual rate of
pneumococcal bacteremia in individuals aged >65 to
range between 53 and 85/100,0004. The pneumococcal
pneumonia mortality is also higher in the elderly, ac-
cording to some studies ranging between 30% and 43%,
which is almost twofold than the one recorded for all age
groups taken together5.
Pneumococcal disease is more common and more se-
vere in patients with chronic diseases such as cardiac
decompensation, nephrotic syndrome, chronic obstruc-
tive pulmonary disease, diabetes mellitus, alcoholism,
and liver cirrhosis6. The risk of pneumococcal disease
morbidity and mortality is higher in splenectomized in-
dividuals and in those with impaired spleen function.
The risk of pneumococcal disease is also increased in in-
dividuals with various forms of immunodeficiency, in-
cluding lymphoma and leukemia patients, patients with
other malignancies on chemotherapy, organ transplan-
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tation patients, and patients suffering from acquired
immunodeficiency syndrome (AIDS and HIV positive in-
dividuals)7.
Indications for vaccination with polyvalent pneumo-
coccal vaccine are set according to the existence and risk
of pneumococcal pneumonia, whereby the ever more
common and significant occurrence of antibiotic resis-
tant pneumococcal strains makes the practice of vacci-
nation a highly relevant public health and economic
issue8.
Although the risk of subsequent pneumonia is known
to be increased in elderly hospitalized patients irrespec-
tive of the cause of hospitalization, some studies suggest
that it is even higher in elderly patients hospitalized for
pneumonia than in those hospitalized for other dis-
eases.
The aim of this retrospective study was to determine
the relationship of hospital stay for pneumonia and
some other diseases with subsequent pneumonia mor-
bidity and mortality. The results of the study were ex-
pected to help improve the elderly protection from pneu-
monia by a set of measures, from health education to
target vaccination.
Materials and Methods
The risk of pneumonia recurrence in patients al-
ready hospitalized for pneumonia was investigated dur-
ing a 3-year period (1998–2000). Rehospitalization of
pneumonia patients previously hospitalized for the dis-
ease was followed-up and compared with rehospita-
lization of patients hospitalized during the same perod
of time for other diseases. The study included patients
over 18 years of age, initially hospitalized in 1998 for
pneumonia (J12–J18), or for some particular gastroin-
testinal (K20–K31*) and urogenital diseases (N10–
N12**, N30–N39***). All rehospitalizations for pneu-
monia in nine Zagreb hospitals**** were followed-up by
means of citizen identification number. All cases of
pneumonia rehospitalized within a month from the ini-
tial discharge from hospital were excluded, because
they were considered to have been inadequately cured
from the previous disease episode rather than suffering
from a disease recurrence.
The study subjects were divided into two groups:
group 1 (PN) – patients hospitalized for pneumonia
(J12–J18); and group 2 (CONT) – patients hospitalized
for esophagogastroduodenal diseases (K20–K31), pyelo-
nephritis (N10–N12) and other urinary tract diseases
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* K20 Esophagitis, K21 Gastroesophageal reflux, K22 Other esophageal diseases, K25 Gastric ulcer, K26 Duodenal ulcer, K27 Peptic ulcer of unspeci-
fied localization, K28 Gastrojejunal ulcer, K29 Gastritis and duodenitis, K30 Dyspepsia
** N10 Acute tubulointerstitial nephritis, N11 Chronic tubulointerstitial nephritis, N12 Tubulointerstitial nephritis unspecified
*** N30 Cystitis, N31 Neuromuscular urinary bladder dysfunction, N32 Other urinary bladder disorders, N34 Urethritis, N35 Urethral stricture, N36
Other urethral disorders, N39 Other urinary system disorders
**** Zagreb University Hospital Center, Sestre milosrdnice University Hospital, University Hospital for Tumors, University Hospital of Traumatology,
Dubrava University Hospital, Merkur University Hospital, Jankomir Psychiatry Hospital, Vrapce Psychiatry Hospital, Special Hospital for Chronic
Diseases
TABLE 1
TABLE OF CONTINGENCY – PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DIAGNOSES DURING 1998 ACCORDING





18–49 Na 30 209 239
hpb 12.6% 87.4% 100.0%
vpc 13.2% 27.9% 24.5%
50–64 N 56 189 245
hp 22.9% 77.1% 100.0%
vp 24.7% 25.3% 25.1%
65–84 N 128 328 456
hp 28.1% 71.9% 100.0%
vp 56.4% 43.9% 46.8%
85–99 N 13 22 35
hp 37.1% 62.9% 100.0%
vp 5.7% 2.9% 3.6%
Total N 227 748 975
hp 23.3% 76.7% 100.0%
2-test 2=25.047 df=3 p<0.001
anumber of cases; bpercentage relative to horizontal sum; cpercentage relative to vertical sum
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(N30–N39). The study included a total of 975 patients,
227 of whom initially hospitalized for pneumonia and
748 hospitalized for other specified diagnoses, which
acted as a control group.
The data used in this study were obtained from hos-
pitalization database kept for the City of Zagreb at the
Zagreb Public Health Institute9. The data on all pa-
tients hospitalized at Zagreb hospitals during the cur-
rent year are entered in the database by use of a legally
regulated patient – statistical form. The form is filled-
out on patient discharge from any inpatient health in-
stitution irrespective of its ownership. The data are
linked to a particular person (first name, family name,
citizen identification number), and are entered in the
form irrespective of whether the patient is being dis-
charged from the hospital for home care, transferred to
another institution, or he/she died. A single form is
filled-out for each hospitalization (transfer to another
department of the same hospital is not considered hospi-
tal stay discontinuation, thus no new hospitalization
form is filled-out)10. In the present study, the patient
data (age and sex) and the following hospital stay data
were investigated: date of admission, date of discharge,
main diagnosis on discharge and cause of death in case
of patient death. Regarding the data entry, some rules
were respected: date of admission had to fall within the
current or preceding year, whereas the total number of
hospital days could not exceed 365; the date of discharge
had to fall within the year examined for hospital mor-
bidity; the codes of the International Classification of
Diseases and Related Health Problems (ICD-X) were
used in entering the main diagnosis for hospitalization;
in case of death, the main cause was defined according
to ICD-X following World Health Organization regula-
tions.
In this study the observational epidemiologic method
free from any artificial manipulation with the study fac-
tor was used. A descriptive method of investigation was
employed, including the presentation of the current
state and all time-related disease variations observed
(3-year disease pattern) as well as the individuals af-
fected, e.g., age and sex11.
A statistical analysis of the work hypotheses was
performed by use of nonparametric methods (mostly
2-test) for variables expressed as categories (age groups).
The hypotheses related to continuous variables (number
of hospital days) were tested by the analysis of variance.
Results
A total of 975 patients hospitalized in Zagreb hospi-
tals were followed-up, including 227 (23.3%) patients
initially hospitalized for pneumonia (group 1) and 748
(76.7%) patients initially hospitalized for other diagno-
ses (group 2).
In the course of the follow-up period, 30 patients
were affected with and rehospitalized for pneumonia,
including 22 group 1 patients (the group of patients ini-
tially hospitalized for pneumonia) and 8/748 group 2 pa-
tients (the group of patients initially hospitalized for
other diseases), yielding a statistically significant be-
tween-group difference (2=34.780, p<0.001).
Sex analysis according to patient groups showed no
statistically significant between-group difference, the
patient sex distribution being quite uniform. In group 1,
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TABLE 2
TABLE OF CONTINGENCY – PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DIAGNOSES, AND REHOSPITALIZED FOR




PNd PN-Re CONTf CONT-Rg
18–49 Na 28 2 208 1 239
hpb 11.7% 0.8% 87.0% 0.4% 100.0%
vpc 13.7% 9.1% 28.1% 12.5% 24.5%
50–64 N 51 5 189 245
hp 20.8% 2.0% 77.1% 100.0%
vp 24.9% 22.7% 25.5% 25.1%
65–84 N 113 15 322 6 456
hp 24.8% 3.3% 70.6% 1.3% 100.0%
vp 55.1% 68.2% 43.5% 75.0% 46.8%
85–99 N 13 21 1 35
hp 37.1% 60.0% 2.9% 100.0%
vp 6.3% 2.8% 12.5% 3.6%
Total N 205 22 740 8 975
hp 21.0% 2.3% 75.9% 0.8% 100.0%
2-test 2=34.780 df=9 p<0.001
anumber of cases; bpercentage relative to horizontal sum; cpercentage relative to vertical sum; dgroup of pneumonia patients without
rehospitalization; egroup of pneumonia patients with rehospitalization; fgroup of other disease patients without rehospitalization;
ggroup of other disease patients with rehospitalization
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women accounted for 41.4% and men for 58.6%, whereas
in group 2 the respective figures were 44.7% and 55.3%.
In group 1, 59.1% of female and 40.9% of male patients
were rehospitalized for pneumonia.
As the risk of pneumonia morbidity and mortality is
age related, all patients from both groups were divided
into the following age subgroups: 18–49, 50–64, 65–84
and 85–99 years (Table 1). The patients belonging to
older age groups prevailed, with the exception of >85
age group, which accounted for 3.6% of the total number
of study patients. The 65–84 age group prevailed (46.8%),
followed by 50–64 age group (25.1%). The individuals
aged 65–84 predominated in both study groups, ac-
counting for 56.4% and 43.9% of group 1 and group 2 pa-
tients, respectively, followed by younger patients aged
18–49 (27.9%).
The analysis of age distribution of 22 PN group pa-
tients rehospitalized for pneumonia (PN-R subgroup)
revealed the 65–84 age groups to prevail (N=15, 68.2%).
In CONT group, eight patients required rehospitaliza-
tion (CONT-R subgroup), six of them aged 65–84, ac-
counting for 75.0% of all rehospitalizations recorded in
CONT group. In PN-R subgroup, the 50–64 age group
patients were the second most frequent in terms of
rehospitalization rate (N=5, 22.7%). In this subgroup,
there was no patient older than 85 requiring rehospita-
lization, whereas in the CONT-R subgroup one patient
aged >85 and one patient from 18–49 age group were
rehospitalized for pneumonia (Table 2).
In PN group (primary hospitalization for pneumo-
nia), the mean age was 66.00 (range 18–94) years, and
in PN-R subgroup (rehospitalization in PN group) 65.91
(range 38–81) years. In CONT group (primary hospital-
ization for other diagnoses), the patients were some-
what younger than those from PN group, the mean age
being 59.26 (range 18–94) years, whereas the patients
from the CONT-R subgroup (rehospitalization in CONT
group) were the oldest, their mean age being 73.88
(range 40–94) years, which indicated that those hospi-
talized for other diagnoses were less frequently affected
by the severe form of pneumonia requiring hospitaliza-
tion in spite of their considerably older age (Table 3).
In the course of the 1998–2000 period, 161 patients
from both study groups died, accounting for 16.5% of the
total number of study subjects; there were 55 (34.2%)
PN group (primary hospitalization for pneumonia) and
106 (65.8%) CONT group (primary hospitalization for
other diagnoses) patients, yielding a statistically signifi-
cant difference (2=40.368, p<0.001). Out of all deaths
recorded during the study period, 20 (12.4%) were di-
rectly caused by pneumonia, and the rest of deaths were
due to other causes. Out of 20 patients who died from
pneumonia, ten were from PN group, and only one was
from CONT group, the difference being statistically sig-
nificant (2=15.82, p<0.001).
In group 1, 36 patients died from other diagnoses, ac-
counting for 65.5%, whereas deaths due to pneumonia
accounted for 34.5% of the total number of deaths in this
group. In group 2, only one patient died from pneumonia
and all other deaths were due to other causes, account-
ing for 0.9% and 99.1% of 106 deaths in this group (Ta-
ble 4).
According to the sequence of hospital stay, the major-
ity of deaths (N=152, 94.4%) occurred during initial hos-
pitalization (Table 5). Out of these 152 deaths during
initial hospitalization, 47 (29.2%) and 105 (65.2%) were
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TABLE 3A
PARAMETERS OF AGE DISTRIBUTION OF PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DISEASES, AND OF PATIENTS
REHOSPITALIZED FOR PNEUMONIA DURING THE 1998–2000 PERIOD, AND TOTAL FIGURES




PNa 205 66.00 14.86 1.04 63.96 68.05 18 94
PN-Rb 22 65.91 11.99 2.56 60.59 71.23 38 81
CONTc 740 59.26 16.13 0.59 58.10 60.43 18 94
CONT-Rd 8 73.88 16.16 5.71 60.36 87.39 40 92
Total 975 60.95 16.07 0.51 59.94 61.96 18 94
agroup of pneumonia patients without rehospitalization; bgroup of pneumonia patients with rehospitalization; cgroup of other dis-
ease patients without rehospitalization; dgroup of other disease patients with rehospitalization; SD=standard deviation; SE=stan-
dard error
TABLE 3B
ANALYSIS OF VARIANCE FOR AGE OF PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DISEASES, AND REHOSPITALIZED
FOR PNEUMONIA DURING THE 1998–2000 PERIOD
Source of variability Sum of Squares df Mean Square F p
Between groups 9220.896 3 3073.632 12.318 <0.001
Within groups 242286.308 971 249.522
Total 251507.204 974
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due to pneumonia and other diagnoses, respectively.
Nine patients died during rehospitalization, eight (5%)
of them from PN group (PN-R subgroup) and only one
(0.6%) from CONT group (CONT-R subgroup). The ma-
jority of deaths due to pneumonia (N=15, 75.0%) occurred
during the primary hospital stay. During rehospitali-
zation, four PN (PN-R) patients and only one CONT
(CONT-R) patient died from pneumonia.
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TABLE 4
TABLE OF CONTINGENCY – DEATHS IN PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DISEASES DURING





J12–18d Na 19 1 20
hpb 95.0% 5.0% 100.0%
vpc 34.5% 0.9% 12.4%
K20–31e N 7 7
hp 100.0% 100.0%
vp 6.6% 4.3%
N10–12 i 30–39f N 2 2
hp 100.0% 100.0%
vp 1.9% 1.2%
Other diagnoses N 36 96 132
hp 27.3% 72.7% 100.0%
vp 65.5% 90.6% 82.0%
Total N 55 106 161
hp 34.2% 65.8% 100.0%
2-test 2=40.368 df=3 p<0.001
anumber of cases; bpercentage of horizontal sum; cpercentage of vertical sum; dpneumonia; eesophagogastroduodenal diseases; fpy-
elonephritis and other urinary tract diseases
TABLE 5
TABLE OF CONTINGENCY – DEATHS IN PATIENTS HOSPITALIZED FOR PNEUMONIA AND OTHER DISEASES, AND





PNg PN-Rh CONTi CONT-Rj
J12–18d Na 15 4 1 20
hpb 75.0% 20.0% 5.0% 100.0%
vpc 31.9% 50.0% 100.0% 12.4%
K20–31e N 7 7
hp 100.0% 100.0%
vp 6.7% 4.3%
N10–12 i 30–39f N 2 2
hp 100.0% 100.0%
vp 1.9% 1.2%
Other diagnoses N 32 4 96 132
hp 24.2% 3.0% 72.7% 100.0%
vp 68.1% 50.0% 94.1% 82.0%
Total N 47 8 105 1 161
hp 29.2% 5.0% 65.2% 0.6% 100.0%
2-test 2=51.555 df=9 p<0.001
anumber of cases; bpercentage of horizontal sum; cpercentage of vertical sum; dpneumonia; eesophagogastroduodenal diseases; fpy-
elonephritis and other urinary tract diseases; ggroup of pneumonia patients without rehospitalization; hgroup of pneumonia pa-
tients with rehospitalization; igroup of patients with other diseases without rehospitalization; jgroup of patients with other diseases
with rehospitalization
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The overall mean age of patients who died from all
causes was 69.76 (range 26–94) years. Those who died
from pneumonia were on an average older, their mean
age being 74.90 (range 54–94) years (Table 6).
Discussion
In Croatia and in the City of Zagreb, the proportion
of individuals older than 65 is on an increase, entailing
an ever growing burden of elderly population at the so-
cial, medical and health care level in general. Pneumo-
nia is a common cause of morbidity and mortality in the
elderly. The elderly are more frequently hospitalized for
pneumonia, their hospital stay is longer and the treat-
ment outcome poorer than in younger persons12. The
higher rate of affection with particular diseases at an
advanced age can be explained by chronic disease co-
morbidity. This is evident in pulmonary diseases, where
pneumonia occurs more commonly due to the existing
respiratory tract and lung lesions as well as the coexis-
tence of congestive cardiac insufficiency13.
The pneumococcal vaccine provides an efficient pro-
tection of the individuals at risk, including the elderly,
from invasive pneumococcal disease or bacteremia, al-
though the data do not show the same efficacy of protec-
tion from pneumococcal pneumonia at an advanced
age14–16. However, many authors agree that the protec-
tion from invasive pneumococcal disease provided by
the vaccine justifies its use in the elderly and other
groups at risk, the more so as pneumococcal pneumonia
is a major cause of bacteremia5,17. A cost-effectiveness
analysis carried out in the USA pointed to dual savings
achieved by vaccination of the population aged over 65
for protection from pneumococcal bacteremia: their
health improvement and direct cost reduction through
the prevention the disease development. The analysis
was based on health care model and QALY (quality-ad-
justed life year) index, comparing the price of a vaccine
dose to the price of treatment for pneumococcal bactere-
mia18. Tengs et al. refer to vaccination of the elderly with
pneumococcal vaccine as to one of the most cost-effective
measures among 500 life-saving interventions under-
taken for the sake of prolongation of life expectancy in
the elderly19.
Some studies point to the public health, also imply-
ing an economically favorable effect of vaccination of the
elderly following hospitalization for pneumonia20. In
their study carried out in the USA, Fedson et al. demon-
strated that 6% to 9% of elderly patients hospitalized for
pneumonia would require rehospitalization for the same
disease within the next 5 years. These results confirm
the rationality of vaccination of the elderly following an
inpatient treatment for pneumonia21.
The results of the present study also showed the risk
of pneumonia recurrence and rehospitalization in the
course of 3 years after primary hospitalization to be al-
most threefold with both pneumonia as the initial diag-
nosis and other diagnoses (ratio 22:8). The mean age of
rehospitalized patients with the initial diagnosis of pneu-
monia was lower than the mean age of rehospitalized
patients with other initial diagnoses (65.9 vs 73.9 years),
in spite of the ratio being opposite on primary hospital-
ization. This finding suggests that those hospitalized for
other diseases were less frequently affected with a se-
vere form of pneumonia, which requires hospitalization,
and even this only at a considerably older age. The mor-
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TABLE 6A
PARAMETERS OF AGE DISTRIBUTION OF PATIENTS DECEASED DURING THE 1998–2000 PERIOD ACCORDING TO
DEATH DIAGNOSIS




h1 h2 Min Max
J12–18a 20 74.90 10.88 2.43 69.81 79.99 54 94
K20–31b 7 70.00 7.79 2.94 62.80 77.20 61 80
N10–12 i 30–39c 2 60.00 7.07 5.00 –3.53 123.53 55 65
Other diagnoses 132 69.11 11.93 1.04 67.06 71.17 26 94
Total 161 69.76 11.75 0.93 67.93 71.59 26 94
apneumonia; besophagogastroduodenal diseases; cpyelonephritis and other urinary system diseases; SD=standard deviation; SE=
standard error
TABLE 6B
ANALYSIS OF VARIANCE FOR AGE OF THE DECEASED DURING THE 1998–2000 PERIOD ACCORDING TO DEATH DIAGNOSIS
Source of variability Sum of Squares df Mean Square F p
Between groups 774.46 3 258.152 1.903 0.131
Within groups 21302.10 157 135.682
Total 22076.55 160
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tality directly due to pneumonia was also significantly
higher in the group of patients with the initial diagnosis
of pneumonia (34.5%) than in the group of patients with
other initial diagnoses (0.9%). The patients who died
from pneumonia were on an average older than the
overall mean age at death from all causes (74.9 vs 69.8
years). Hedlund et al. demonstrated in their study of
573 patients hospitalized for pneumonia or other diag-
noses that the risk of rehospitalization for pneumonia
during the 3-year follow-up was nearly fivefold if the ini-
tial diagnosis had been pneumonia and that the mortal-
ity was also significantly higher, especially in those
older than 5022. This appears to suggest the conclusion
that a previous episode of inpatiently treated pneumo-
nia is an important indicator of an increased risk of dis-
ease recurrence and death from pneumonia. As Strepto-
coccus pneumoniae is the leading cause of pneumonia in
the elderly, it is concluded that vaccination of this popu-
lation group with pneumococcal vaccine following hospi-
talization for pneumonia would be a highly cost-effec-
tive method for prevention of pneumonia recurrence
and rehospitalization.
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RIZIK PONOVNOG OBOLIJEVANJA OD PNEUMONIJE KOD BOLESNIKA PRETHODNO
HOSPITALIZIRANIH ZBOG PNEUMONIJE – RETROSPEKTIVNO ISTRA@IVANJE OD 1998.
DO 2000. GODINE
S A @ E T A K
Iako je poznato da starijim hospitaliziranim bolesnicima (bez obzira na uzrok hospitalizacije) prijeti ve}i rizik da
poslije obole od pneumonije, prema nekim istra`ivanjima taj je rizik jo{ ve}i za osobe hospitalizirane zbog pneumonije
nego za one koji su hospitalizirani zbog drugih bolesti. Cilj ovog rada je retrospektivnim istra`ivanjem poku{ati utvr-
diti povezanost izme|u boravka u bolnici zbog pneumonije i nekih drugih uzroka bolesti, s naknadnim morbiditetom,
odnosno mortalitetom od pneumonije. Istra`ivali smo rizik od ponovnog obolijevanja od pneumonije za bolesnike ve}
hospitalizirane zbog pneumonije. Pratile su se i usporedile ponovne hospitalizacije oboljelih od pneumonije, koji su
jednom ve} bili hospitalizirani zbog te bolesti, s ponovnom hospitalizacijom bolesnika koji su u istom razdoblju bili
hospitalizirani zbog drugih uzroka. Istra`ivani bolesnici bili su stariji od 18 godina, prvi put hospitalizirani tijekom
1998. godine zbog pneumonije (J12–J18), pojedinih gastrointestinalnih (K20–K31) i urogenitalnih bolesti (N10–N12,
N30–N39). Tijekom tri godine pratile su se sve ponovne hospitalizacije zbog pneumonije u devet zagreba~kih bolnica.
Od ukupno 975 osoba pra}enih zbog ponovne hospitalizacije, 227 (23,3%) hospitalizirano je zbog pneumonije, a 748
(76,7%) zbog drugih dijagnoza. Tijekom tri godine je zbog pneumonije ponovno hospitalizirano 30 osoba, od kojih 22
bolesnika prvi put hospitaliziranih zbog pneumonije, {to je statisti~ki zna~ajna razlika izme|u pra}enih skupina
(2=34,780; p<0,001). Mortalitet izravno uzrokovan pneumonijom tako|er je zna~ajno vi{i u skupini s inicijalnom
dijagnozom pneumonije nego u drugoj skupini (2=15,82; p<0,001).
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